Gastric metastasis from ovarian cancer is rarely reported worldwide. In Korea, only 2 such cases have been reported. Here we report a case of a 58-year-old woman with metastatic gastric cancer from an ovarian adenocarcinoma. Endoscopic examination showed that the cancer presented as a submucosal tumor without ulceration. A subsequent gastrectomy confirmed the diagnosis of metastatic ovarian serous adenocarcinoma.
Introduction
Although ovarian cancer usually spreads along the peritoneum and throughout the pelvic and abdominal cavities, gastrointestinal involvement is uncommon. 1 Metastatic gastric cancer from ovarian cancer is extremely rare. 2 In Korea, only 2 instances of gastric metastasis from ovarian adenocarcinoma have been described. 2, 3 Here we report an additional case that presented as a submucosal tumor without ulceration during an endoscopic ultrasound (EUS) and endoscopic examination. The diagnosis of metastatic ovarian cancer was confirmed by post-gastrectomy histopathological examination.
Case Report
In January 2014, a 58-year-old woman was admitted to our department with a gastric submucosal tumor that was recently discovered during a routine checkup and gastroduodenoscopy. She and paraaortic lymph node dissection with total omentectomy, followed by 6 cycles of adjuvant chemotherapy with carboplatin and paclitaxel. In 2012, the patient was re-examined and found to have newly developed seeding metastases in the perihepatic space, omentum, perirectal area, diaphragm, and external iliac chain. Her CA-125 level had increased to 51.06 U/ml. Following a debulking operation, she received 9 additional cycles of adjuvant chemotherapy with the previously described regimen. Subsequently, the CA-125 levels were tested every 3 months. After the additional chemotherapy, it had decreased to the normal range and a radiologic examination revealed tumor regression.
The gastric submucosal tumor found in January 2014 was a 2 cm low-echogenic lesion located on the greater curvature of the antrum and showed irregularity in the propria muscle layer (Fig. 1) .
The pathological diagnosis from the endoscopic biopsy before the operation was chronic active gastritis. 
Discussion
Metastatic disease involving the stomach is unusual. Most gastric metastases arise from primary breast cancer, followed by melanoma and lung cancer. The incidence of gastric metastasis is 3.6% in patients with breast cancer and 1.3% in patients with lung cancer. 1 In Korea, several cases of gastric metastasis from breast cancer, lung cancer, and cholangiocarcinoma, among others, have been reported. [4] [5] [6] The clinical manifestations of metastasis to the stomach vary, but include epigastric pain, melena, anemia from occult gastrointestinal blood loss, nausea, and vomiting. However, our patient did not complain of any symptoms.
Ovarian tumors comprise only 0.013% to 1.6% of all gastric metastatic tumors. 7 Reports worldwide of gastric metastases from ovarian cancer are rare. Ovarian carcinomas are more likely to metastasize along the peritoneal surface due to exfoliating cells implanted throughout the peritoneum. In fact, the intraperitoneal route is considered to be the most common route of dissemination. 7 However, in the present case, there was no evidence of peritoneal metastasis after preoperative studies, including an abdominal CT scan. We carefully examined the whole abdominal cavity to rule out seeding. The surface of the stomach was normal, except for multiple enlarged perigastric lymph nodes. Ovarian carcinoma can me- In addition, endoscopic submucosal dissection (ESD) with enucleation might be a viable option. In our case, however, ESD with enucleation was not an option owing to the presence of metastases in multiple lymph nodes. Kang et al. 3 reported a case of primary ovarian carcinoma with gastric metastasis that mimicked gastrointestinal stromal tumor (GIST), which was diagnosed after the patient underwent gastric antrectomy. Similarly, in the present case, we suspected that the gastric lesion was most likely GIST. On the basis of the patients medical history, we considered the possibility of either breast cancer or ovarian cancer metastasis.
Our initial diagnosis of the submucosal gastric lesion was confirmed to be gastric metastasis from ovarian cancer. The best longterm survival strategy for advanced ovarian cancer is primary debulking surgery. 8 According to the National Comprehensive Cancer Network (NCCN) guidelines for ovarian cancer, secondary cytoreductive surgery can be considered for patients with recurring cancer after a long disease-free interval (6 months or more). 9 While in our case, the patient's cancer recurred twice, and her last disease-free interval was more than 6 months. Therefore, gastric resection with lymphadenectomy would be the optimal treatment strategy. EUS with fine needle aspiration or biopsy is useful for the correct diagnosis of gastric submucosal lesions. 7 In our case, EUS-guided fineneedle aspiration or biopsy would have ideally been applied prior to surgery. Additionally, as the patient had multiple primary cancers (thyroid cancer, breast cancer, and ovarian cancer), a further genetic analysis to detect BRCA1 or 2 mutations might be indicated.
In conclusion, although rare, a diagnosis of gastric metastasis from ovarian cancer should be considered in patients with a submucosal gastric tumor and a history of ovarian cancer.
